Abnormal folate metabolism in foetuses affected by neural tube defects
Open Access
- 21 November 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 130 (4) , 1043-1049
Abstract
Folic acid supplementation can prevent many cases of neural tube defects (NTDs), whereas suboptimal maternal folate status is a risk factor, suggesting that folate metabolism is a key determinant of susceptibility to NTDs. Despite extensive genetic analysis of folate cycle enzymes, and quantification of metabolites in maternal blood, neither the protective mechanism nor the relationship between maternal folate status and susceptibility are understood in most cases. In order to investigate potential abnormalities in folate metabolism in the embryo itself, we derived primary fibroblastic cell lines from foetuses affected by NTDs and subjected them to the dU suppression test, a sensitive metabolic test of folate metabolism. Significantly, a subset of NTD cases exhibited low scores in this test, indicative of abnormalities in folate cycling that may be causally linked to the defect. Susceptibility to NTDs may be increased by suppression of the methylation cycle, which is interlinked with the folate cycle. However, reduced efficacy in the dU suppression test was not associated with altered abundance of the methylation cycle intermediates, s-adenosylmethionine and s-adenosylhomocysteine, suggesting that a methylation cycle defect is unlikely to be responsible for the observed abnormality of folate metabolism. Genotyping of samples for known polymorphisms in genes encoding folate-associated enzymes did not reveal any correlation between specific genotypes and the observed abnormalities in folate metabolism. These data suggest that as yet unrecognized genetic variants result in embryonic abnormalities of folate cycling that may be causally related to NTDs.Keywords
This publication has 31 references indexed in Scilit:
- Neural tube defects and folate: case far from closedNature Reviews Neuroscience, 2006
- Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryosFEBS Letters, 2006
- Candidate gene analysis in human neural tube defectsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2005
- Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control studyBMJ, 2004
- The genetic basis of mammalian neurulationNature Reviews Genetics, 2003
- New 19 bp deletion polymorphism in intron‐1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy?American Journal of Medical Genetics Part A, 2003
- Studies with His475Tyr glutamate carboxipeptidase II polymorphism and neural tube defectsAmerican Journal of Medical Genetics, 2002
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Effect of Deoxyuridine on Incorporation of Tritiated Thymidine: Difference Between Normoblasts and MegaloblastsActa Medica Scandinavica, 1964